Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Merck & Co Inc Hit With $285,000 Verdict In Fosamax Trial-Reuters


Tuesday, 5 Feb 2013 03:26pm EST 

Reuters reported that A federal jury has ordered Merck & Co Inc to pay $285,000 in a lawsuit over the risks of its osteoporosis drug Fosamax. Merck said in a statement that it disagreed with the verdict and noted that the jury returned a mixed verdict. 

Company Quote

56.8
0.06 +0.11%
1 Aug 2014